← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › QUINOLONE ANTIBACTERIALS › Other quinolones
nalidixic acid
J01MB02
Forms & Strengths
- Tablets: 250mg, 500mg, 750mg
- Capsules: 250mg, 500mg
- Suspension: 250mg/5mL
Adult Dosing
- Urinary tract infections: 1g every 6 hours
- Complicated infections: 1g every 4-6 hours
- Maximum dose: 4g/day
Pediatric Dosing
- Infants >3 months and children: 55mg/kg/day divided into 4 doses
- For children >12 years, use adult dosing
Indications
- Uncomplicated urinary tract infections
- Complicated urinary tract infections
- Prostatitis
Mechanism of Action
- Inhibits bacterial DNA gyrase and topoisomerase IV
- Interferes with DNA replication and transcription
Contraindications
- Hypersensitivity to nalidixic acid or quinolones
- Pregnancy and breastfeeding
- Children <3 months
Adverse Reactions
- Gastrointestinal disturbances
- Allergic reactions
- CNS effects: dizziness, headache, seizures
- Hepatotoxicity and renal toxicity
Drug Interactions
- Antacids: decrease absorption
- Sucralfate: decrease absorption
- Warfarin: increased anticoagulant effect
- Theophylline: increased theophylline levels
Curated Content: Needs Vetting Before Put to Clinical Use